REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

NCT07476339 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

HIV -1 Infection
HIV (Human Immunodeficiency Virus)
HIV
HIV 1 Infection

Interventions

DRUG: Bictegravir, emtricitabine, and tenofovir alafenamide

Sponsor

CAN Community Health

Collaborators

[object Object]
[object Object]
[object Object]